Yanfang Zhao, Wenjia Su, Guohua Liang, Xiaoyu Shan, Weiwei Ma, Dabei Tang, . . . Wenhui Zhao. (2021). High dose and hepatobiliary dysfunction are associated with hand-foot syndrome in patients with lymphoma using pegylated liposomal doxorubicin: A retrospective study. BMC.
Chicago Style (17th ed.) CitationYanfang Zhao, et al. High Dose and Hepatobiliary Dysfunction Are Associated with Hand-foot Syndrome in Patients with Lymphoma Using Pegylated Liposomal Doxorubicin: A Retrospective Study. BMC, 2021.
MLA (9th ed.) CitationYanfang Zhao, et al. High Dose and Hepatobiliary Dysfunction Are Associated with Hand-foot Syndrome in Patients with Lymphoma Using Pegylated Liposomal Doxorubicin: A Retrospective Study. BMC, 2021.
Warning: These citations may not always be 100% accurate.